$1.660
-0.210 (-12.63%)At close
Technical Sentiment
Overall Consensus
Technical Analysis Consensus
Moving Average Consensus
Black Diamond Therapeutics Inc (BDTX) Moving Averages Convergence Divergence (MACD) indicator is -0.03, suggesting BDTX is Strong sell.
Black Diamond Therapeutics Inc (BDTX) 20-Day simple moving average is 1.82, while Black Diamond Therapeutics Inc (BDTX) share price is $—, making it Sell.
Black Diamond Therapeutics Inc (BDTX) 60-Day simple moving average is 1.95, while Black Diamond Therapeutics Inc (BDTX) share price is $—, making it Sell.
Technical Analysis for BDTX
AI Technical BDTXAs of 2026-11-03, the technical board for Black Diamond Therapeutics Inc (BDTX) reads strong sell: 0 indicators are flashing buy, 9 are indicating sell, and 4 are neutral. Price at $1.66 sits below every tracked moving average (5-day, 10-day, 20-day, 60-day and 200-day).
Momentum readings: RSI stands at 41.294, MACD stands at -0.0322 (Sell), Stochastic %K stands at 29.293, Stochastic %D stands at 31.828 and CCI stands at -64.785.
BDTX trades below the 60-day SMA (1.95) and below the 200-day SMA (2.18). Immediate resistance sits at Classic R1 2.01, then R2 2.23. Support sits at Classic S1 1.61, then S2 1.42.
Black Diamond Therapeutics Inc (BDTX) Support & Resistance Level
Black Diamond Therapeutics Inc (BDTX) Technical Indicators
2026-11-03
| Name | Value |
|---|---|
| RSI_14 | 41.294 |
| STOCHk_14_3_3 | 29.293 |
| STOCHd_14_3_3 | 31.828 |
| CCI_20 | -64.785 |
| AO_5_34 | -0.025 |
| MOM_10 | -0.420 |
| MACD_12_26_9 | -0.032 |
Black Diamond Therapeutics Inc (BDTX) Relative Strength Index (RSI_14) is 41.294, creating a Neutral signal.
Black Diamond Therapeutics Inc (BDTX) Stochastic %K is 29.293, creating a Neutral signal.
Black Diamond Therapeutics Inc (BDTX) Stochastic %D is 31.828, creating a Neutral signal.
Black Diamond Therapeutics Inc (BDTX) CCI_20 is -64.785, creating a Neutral signal.
Black Diamond Therapeutics Inc (BDTX) Awesome Oscillator (AO) is -0.025, creating a Sell signal.
Black Diamond Therapeutics Inc (BDTX) Momentum (MOM) is -0.420, creating a Sell signal.
Black Diamond Therapeutics Inc (BDTX) Moving Average Convergence Divergence (MACD) is -0.032, creating a Sell signal.
Black Diamond Therapeutics Inc (BDTX) Moving Average
2026-11-03
| Period | Simple | Signal |
|---|---|---|
| MA_5 | 1.780 | Sell |
| MA_10 | 1.791 | Sell |
| MA_20 | 1.819 | Sell |
| MA_60 | 1.951 | Sell |
| MA_200 | 2.176 | Sell |
| MA_250 | 2.361 | Sell |
Black Diamond Therapeutics Inc (BDTX) 5-Day simple moving average is 1.780, while Black Diamond Therapeutics Inc (BDTX) share price is $, making it a Sell.
Black Diamond Therapeutics Inc (BDTX) 10-Day simple moving average is 1.791, while Black Diamond Therapeutics Inc (BDTX) share price is $, making it a Sell.
Black Diamond Therapeutics Inc (BDTX) 20-Day simple moving average is 1.819, while Black Diamond Therapeutics Inc (BDTX) share price is $, making it a Sell.
Black Diamond Therapeutics Inc (BDTX) 60-Day simple moving average is 1.951, while Black Diamond Therapeutics Inc (BDTX) share price is $, making it a Sell.
Black Diamond Therapeutics Inc (BDTX) 200-Day simple moving average is 2.176, while Black Diamond Therapeutics Inc (BDTX) share price is $, making it a Sell.
Black Diamond Therapeutics Inc (BDTX) 250-Day simple moving average is 2.361, while Black Diamond Therapeutics Inc (BDTX) share price is $, making it a Sell.
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.